The University of Minnesota and the pharmaceutical company Glaxo Wellcome have reached a settlement over the AIDS virus drug Ziagen. The settlement requires Glaxo Wellcome to pay royalties for the patented drug developed at the University. Total royalties are expected to exceed 300 million dollars.
Views and opinions expressed in the content do not represent the opinions of APMG. APMG is not responsible for objectionable content and language represented on the site. Please use the “Contact Us” button if you’d like to report a piece of content. Thank you.
Transcriptions provided are machine generated, and while APMG makes the best effort for accuracy, mistakes will happen. Please excuse these errors and use the “Contact Us” button if you’d like to report an error. Thank you.